H
Haikou Mingheng Biotechnology
Request Full Data Access to the Medutest database of peptide tests.
Products examined
| Product | Rating | Samples | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | D | 5 | 6.2 | 3.8 | 8.0 | 18 Sep 2025 |
| Tirzepatide | E | 6 | 5.5 | 2.3 | 7.8 | 18 Sep 2025 |
| 1-Boc-4-(4-fluorophenylamino)piperidine CAS 288573-56-8 | X | 1 | 5.2 | 5.2 | 5.2 | 9 Jun 2025 |
| 4-AP (4-anilino-piperidine / N-phenyl-4-piperidinamine) CAS 23056-29-3 | X | 1 | 7.1 | 7.1 | 7.1 | 16 Mar 2025 |
| 4-Piperidone CAS 41661-47-6 | X | 1 | 6.9 | 6.9 | 6.9 | 11 Jun 2025 |
| Andarine S4 | X | 1 | 7.2 | 7.2 | 7.2 | 17 Dec 2024 |
| BPC-157 Capsule | X | 1 | 6.5 | 6.5 | 6.5 | 3 Jun 2025 |
| BPC157 5mg + TB500 5mg Blend | X | 1 | 5.5 | 5.5 | 5.5 | 6 May 2025 |
| CJC-1295 With DAC | X | 1 | 7.1 | 7.1 | 7.1 | 14 Jan 2025 |
| DHB (1-Test Cyp) Oral | X | 1 | 5.9 | 5.9 | 5.9 | 11 Jun 2025 |
| Dihexa | X | 1 | 6.9 | 6.9 | 6.9 | 17 Dec 2024 |
| EPO | X | 1 | 7.9 | 7.9 | 7.9 | 11 Jun 2025 |
| GHRP-2 Acetate | X | 1 | 4.0 | 3.7 | 3.7 | 9 Jun 2025 |
| Glutathione | X | 1 | 6.0 | 6.0 | 6.0 | 8 Jul 2025 |
| HMG | X | 1 | 4.4 | 4.4 | 4.4 | 2 Apr 2025 |
| Hyaluronic acid | X | 1 | 4.8 | 4.8 | 4.8 | 3 Jun 2025 |
| Letrozole | X | 1 | 6.9 | 6.9 | 6.9 | 13 Feb 2025 |
| LGD-4033 (Ligandrol) | X | 1 | 7.0 | 7.0 | 7.0 | 3 Jun 2025 |
| Livagen | X | 1 | 7.6 | 7.6 | 7.6 | 9 Jun 2025 |
| MENT (Trestolone Acetate) | X | 1 | 6.1 | 6.1 | 6.1 | 3 Jul 2025 |
| Minoxidil Oral | X | 1 | 5.1 | 5.1 | 5.1 | 13 Jun 2025 |
| MOTS-C | X | 1 | 5.7 | 5.7 | 5.7 | 8 Jul 2025 |
| NA Selank Amidate | X | 1 | 5.9 | 5.9 | 5.9 | 14 Jan 2025 |
| NAD+ | X | 1 | 5.2 | 5.2 | 5.2 | 16 Mar 2025 |
| P21 | X | 1 | 5.0 | 5.0 | 5.0 | 20 Jun 2025 |
| Pinealon | X | 1 | 4.0 | 3.8 | 3.8 | 28 Mar 2025 |
| Semaglutide Raw | X | 1 | 4.0 | 3.8 | 3.8 | 21 May 2025 |
| Semax | X | 1 | 5.5 | 5.5 | 5.5 | 2 Apr 2025 |
| Sleep Blend (GABA 100mg+Histidine 100mg+L-Theanine 50mg+Taurine 100mg+Melatonin 2mg) | X | 1 | 7.8 | 7.8 | 7.8 | 2 Jul 2025 |
| Stanozolol (Winstrol) Raw | X | 1 | 6.4 | 6.4 | 6.4 | 28 Mar 2025 |
| Sustanon 250 | X | 1 | 4.0 | 3.0 | 3.0 | 28 Mar 2025 |
| T3 (Liothyronine) | X | 1 | 5.6 | 5.6 | 5.6 | 3 Jul 2025 |
| Test Base (No Ester) | X | 1 | 6.5 | 6.5 | 6.5 | 7 May 2025 |
| Test Enanthate | X | 1 | 6.4 | 6.4 | 6.4 | 25 Apr 2025 |
| Test Propionate | X | 1 | 4.8 | 4.8 | 4.8 | 2 Apr 2025 |
| Thymosin Alpha-1 | X | 1 | 4.9 | 4.9 | 4.9 | 13 Feb 2025 |
| TriTren 225 | X | 1 | 6.2 | 6.2 | 6.2 | 13 Feb 2025 |
| Turinabol Raw | X | 1 | 7.1 | 7.1 | 7.1 | 16 Mar 2025 |
| Vitamin B12 10mg/ml | X | 1 | 6.4 | 6.4 | 6.4 | 25 Apr 2025 |
| Vitamin D3 20000iu/ml | X | 1 | 6.3 | 6.3 | 6.3 | 2 Apr 2025 |
The certificates
| Date | Product | Score | Declared | Measured | Deviation | Purity | Laboratory |
|---|---|---|---|---|---|---|---|
| 25 May 2026 | BPC-157 Capsule | 6.0 | 25mg | 21.5mg | -13.8% | 98.56% | Lab G |
| 25 May 2026 | Dihexa | 5.0 | 25mg | 22.1mg | -11.5% | 99.80% | Lab F |
| 25 May 2026 | HMG | 4.0 | 20mg | 21.9mg | +9.7% | 97.99% | Lab F |
| 24 May 2026 | 4-AP (4-anilino-piperidine / N-phenyl-4-piperidinamine) CAS 23056-29-3 | 7.5 | 5g | 5.5g | +10.7% | 97.54% | Lab C |
| 24 May 2026 | Glutathione | 7.9 | 20mg | 18.2mg | -9.0% | 98.03% | Lab C |
| 24 May 2026 | Turinabol Raw | 6.1 | 10g | 8.7g | -13.0% | 97.41% | Lab C |
| 24 May 2026 | Semaglutide Raw | 5.0 | 1g | 0.9g | -8.0% | 99.17% | Lab A |
| 24 May 2026 | Thymosin Alpha-1 | 4.5 | 15mg | 17.2mg | +14.3% | 99.80% | Lab G |
| 24 May 2026 | Tirzepatide | 7.8 | 30mg | 31.5mg | +5.0% | 99.80% | Lab G |
| 24 May 2026 | Test Enanthate | 7.2 | 100mg/ml | 112.1mg/ml | +12.1% | 98.91% | Lab B |
| 24 May 2026 | Test Propionate | 4.2 | 250mg/ml | 262.8mg/ml | +5.1% | 96.86% | Lab G |
| 23 May 2026 | Retatrutide | 5.0 | 15mg | 15mg | 96.68% | Lab E | |
| 21 May 2026 | 1-Boc-4-(4-fluorophenylamino)piperidine CAS 288573-56-8 | 4.0 | 100g | 99.5g | -0.5% | 97.79% | Lab B |
| 19 May 2026 | Sleep Blend (GABA 100mg+Histidine 100mg+L-Theanine 50mg+Taurine 100mg+Melatonin 2mg) | 6.5 | 250mg/ml | 237.7mg/ml | -4.9% | 95.17% | Lab D |
| 17 May 2026 | P21 | 4.7 | 20mg | 24.4mg | +22.0% | 97.71% | Lab F |
| 29 Jan 2026 | Tirzepatide | 4.8 | 30mg | 41.6mg | +38.7% | 99.90% | Lab E |
| 19 Jan 2026 | DHB (1-Test Cyp) Oral | 8.1 | 100mg | 112.0mg | +12.0% | 97.69% | Lab A |
| 19 Jan 2026 | Pinealon | 4.0 | 10mg | 11.3mg | +13.2% | 98.51% | Lab C |
| 15 Jan 2026 | Tirzepatide | 2.3 | 10mg | 6.54mg | -34.6% | 98.46% | Lab E |
| 9 Jan 2026 | Semax | 4.3 | 30mg | 33.1mg | +10.3% | 98.15% | Lab B |
| 7 Jan 2026 | Retatrutide | 7.3 | 15mg | 15.3mg | +2.0% | 99.60% | Lab G |
| 7 Jan 2026 | Andarine S4 | 6.6 | 25mg | 26.8mg | +7.2% | 95.72% | Lab E |
| 7 Jan 2026 | Livagen | 8.0 | 5mg | 5.0mg | +0.5% | 99.39% | Lab A |
| 6 Jan 2026 | CJC-1295 With DAC | 7.3 | 50mg | 50.7mg | +1.5% | 95.62% | Lab C |
| 6 Jan 2026 | Minoxidil Oral | 4.6 | 50mg | 43.5mg | -12.9% | 96.93% | Lab B |
| 6 Jan 2026 | T3 (Liothyronine) | 4.8 | 100mg | 85.9mg | -14.1% | 95.40% | Lab A |
| 29 Dec 2025 | TriTren 225 | 6.7 | 250mg/ml | 308.0mg/ml | +23.2% | 98.03% | Lab B |
| 5 Dec 2025 | Vitamin B12 10mg/ml | 4.5 | 200mg/ml | 199.0mg/ml | -0.5% | 96.75% | Lab G |
| 23 Nov 2025 | Sustanon 250 | 4.0 | 300mg/ml | 322.5mg/ml | +7.5% | 96.55% | Lab C |
| 18 Nov 2025 | Retatrutide | 3.8 | 5mg | 5.65mg | +13.0% | 98.90% | Lab E |
| 17 Nov 2025 | Vitamin D3 20000iu/ml | 7.1 | 100mg/ml | 103.3mg/ml | +3.3% | 95.89% | Lab A |
| 14 Nov 2025 | Stanozolol (Winstrol) Raw | 4.5 | 5g | 5.0g | +0.8% | 98.34% | Lab A |
| 14 Nov 2025 | Test Base (No Ester) | 9.3 | 250mg/ml | 218.4mg/ml | -12.6% | 99.20% | Lab F |
| 6 Nov 2025 | Retatrutide | 7.2 | 10mg | 9.59mg | -4.1% | 99.56% | Lab E |
| 5 Nov 2025 | MENT (Trestolone Acetate) | 6.3 | 300mg/ml | 287.4mg/ml | -4.2% | 96.47% | Lab G |
| 5 Nov 2025 | NA Selank Amidate | 5.0 | 50mg | 46.6mg | -6.9% | 97.97% | Lab B |
| 4 Nov 2025 | Letrozole | 7.5 | 20mg | 24.7mg | +23.7% | 95.62% | Lab C |
| 17 Oct 2025 | 4-Piperidone CAS 41661-47-6 | 5.3 | 10g | 8.8g | -11.9% | 98.57% | Lab F |
| 17 Oct 2025 | BPC157 5mg + TB500 5mg Blend | 6.0 | 10mg | 10.6mg | +6.4% | 96.30% | Lab F |
| 17 Oct 2025 | LGD-4033 (Ligandrol) | 7.5 | 100mg | 118.0mg | +18.0% | 98.42% | Lab C |
| 17 Oct 2025 | MOTS-C | 5.7 | 50mg | 52.2mg | +4.3% | 96.76% | Lab E |
| 9 Oct 2025 | EPO | 7.7 | 5mg | 4.3mg | -14.7% | 97.82% | Lab G |
| 9 Oct 2025 | NAD+ | 5.3 | 10mg | 8.6mg | -14.2% | 95.30% | Lab D |
| 3 Oct 2025 | GHRP-2 Acetate | 4.0 | 2mg | 2.4mg | +17.6% | 96.63% | Lab C |
| 3 Oct 2025 | Hyaluronic acid | 4.4 | 2mg | 2.2mg | +9.6% | 95.22% | Lab C |